One-Page Truth-Telling Aid to Guide Cancer Discussions
Official title: A One-Page Truth-Telling Aid for Cancer Disclosure in Taiwan: A Two-Arm Pragmatic Randomized Controlled Trial
Run by Chang Gung University · NCT07730164 · Data updated 2026-11-12
A one-page tool is tested to help doctors quickly understand a cancer patient’s information preferences before a consultation.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Chang Gung University Academic / other |
| Locations | 1 site (Taoyuan) |
| Status | Recruiting |
| Started | November 27, 2025 |
| Main results expected | April 2027 |
| Study ends | July 2027 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07730164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Physicians who treat cancer patients in participating outpatient departments and their eligible Mandarin-speaking cancer patients who can complete questionnaires with or without assistance.
✕Probably not a fit
Patients whose physicians do not adopt the aid or who prefer not to share preferences may see little to no change in communication outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic, two-arm study compares the use of a One-Page Truth-Telling Aid versus a blank question sheet in cancer-related consultations. Physicians in the experimental arm receive the aid to better tailor disclosures to patient preferences, while patients in the control arm use a blank sheet to list questions. The trial looks at patient satisfaction with information, emotional distress after the visit, and physicians’ confidence in communicating about cancer. It is conducted in outpatient oncology settings with Mandarin-speaking participants and involves physician-patient dyads assigned by physician group. The study is designed to assess whether pre-visit alignment on disclosure preferences can improve communication and outcomes in routine care.
Why it matters
Potential benefit: If successful, patients may experience clearer explanations, reduced distress, and a smoother, more person-centered disclosure process.
How similar studies have gone: Prior work suggests structured communication aids can influence satisfaction and perceived clarity, but this exact one-page tool in truth-telling is novel for this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
【Physicians】 * Inclusion Criteria: * Physicians who provide clinical care for patients with cancer in participating outpatient departments. * Physicians who are involved in cancer-related truth-telling or disclosure consultations. * Physicians who are willing to participate and provide informed consent. * Exclusion Criteria: * Physicians who are unable or unwilling to complete study procedures or follow-up assessments. 【Patients】 * Inclusion Criteria: * Patients diagnosed with cancer. * Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status. * Patients who are able to communicate in Mandarin Chinese or Taiwanese. * Patients who are able to complete questionnaires independently or with assistance from the research assistant. * Patients who are willing to participate and provide informed consent. * Exclusion Criteria: * Patients who are unable to provide informed consent. * Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff. * Patients who are unable to complete the study questionnaires even with assistance.
Where it's running
-
Chang Gung University
Taoyuan, Taiwan Recruiting
Study contacts
- Principal investigator: Shih-Ying Chen, PhD — Chang Gung University
- Study coordinator: Shih-Ying Chen, PhD
- Email: s26871193@cgu.edu.tw
- Phone: +886-32118800 #5212
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gender Inclusive Sexuality Talks for Parents and Teens
This trial tests the GIST program to help parents talk with transgender, gender-diverse, lesbian, or bisexual female youth about sexuality at home.
-
PechaKucha-based education to help chemotherapy patients manage symptoms and quality of life
A randomized trial tests whether a 6 minute and 40 second PechaKucha video education session helps adults undergoing chemotherapy manage symptoms and improve quality of life.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Helping Parents Talk About Sexuality with Gay or Bisexual Sons
This study tests Parents ASSIST, a five-session online program to help parents communicate about sexuality with their gay or bisexual sons.
-
Testing AI translation vs. professional translation for knowledge resources for parents
We’re testing whether an AI translation of parent-focused health resources works as well as professional translation for Mandarin, Punjabi, Tagalog, and Urdu-speaking families in Canada.
-
MST-168 first-in-human test in adults with advanced solid tumors
This early-phase study tests MST-168 in adults with target-driven advanced solid tumors to see if it is safe and tolerable and to gather initial signals of activity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.